
ISMP Newsroom
ISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.
Press Coverage

Gaining Efficiencies from Vial Transfer, Admixture Devices
This article appeared on the Pharmacy Practice News website on December 15, 2022
En savoir plusPress Coverage

FDA Alert: Certain LAV Connectors Not Compatible With Prefilled Glass Syringes
This article appeared on the Pharmacy Practice News website on November 23, 2022
En savoir plusPress Coverage

Data, Teamwork Thwart Smart Pump Alert Fatigue
This article appeared on the Specialty Pharmacy Continuum website on November 18, 2022
En savoir plusPress Coverage

Covid-19 Vaccine Labeling Mishaps Persist
The article appeared on the Pharmacy Practice News website on October 19, 2022
En savoir plusPress Coverage

ISMP Releases Survey on Pharmacists’ Support During a Code
This article appeared on the APhA News website on 10/13/22
En savoir plusPress Coverage

Dispensing Sample Medications: Patient Safety Strategies
This article appeared on the Michigan State Medical Society website on October 3, 2022
En savoir plusStay Connected
Get medication safety news, event invitations and updates straight to your inbox!
Social Media
View the Latest from ECRI

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...
En savoir plus
ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award
Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...
En savoir plus
ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides
The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...
En savoir plus